Considering the CSF contactin changes observed in PD patients, we next characterized contactin-1 and contactin-2 expression in post-mortem PD and control brain sections and evaluated their expression in relation to p-Ser129-aSyn, which is one of the main components of LBs and bulgy LNs [30] (Figure 3). This evidence concerns the gene CNTN1 and Parkinson disease.